EGCG for Hepatocellular Carcinoma Chemoprevention (NCT06015022)

🧪 Interventions in This Study

• Epigallocatechin gallate (EGCG) (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• UT Southwestern — Dallas, Texas

📞 Contact the Study Coordinator

Phone: (214) 648-3111

Email: yujin.hoshida@utsouthwestern.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cirrhosis, Liver

• LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study — Ann Arbor, Michigan
• ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement — Phoenix, Arizona
• Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease — Ann Arbor, Michigan
• Angiotensin 2 for AKI After OLT — Los Angeles, California
• Erlotinib for Hepatocellular Carcinoma Chemoprevention — Dallas, Texas
• Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics — Chandler, Arizona

Explore by condition: All Cirrhosis, Liver clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.